References
- Bennet NE. Hypertension in the elderly. Lancet 1994; 344(8920): 447–9
- Black HR. Age-related issues in the treatment of hypertension. Am J Cardiol 1993; 72(20): 10H–13H
- Wilking SV, Belanger A, Kannel WB, et al. Determinants of isolated systolic hypertension. JAMA 1988; 260(23): 3451–5
- Sagie A, Larson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329(26): 1912–7
- Messerli FH. Hypertension in special populations. Med Clin North Am 1997; 81 (6): 1335–45
- Amery A, Fagard R, Guo C, et al. Isolated systolic hypertension in the elderly: an epidemiologic review. Am J Med 1991; 90(3A): 64S-70S
- Frishman WH. Epidemiology, pathophysiology, and management of isolated systolic hypertension in the elderly. Am J Med 1991; 90(4B): 14S–20S
- Mann SJ. Systolic hypertension in the elderly: pathophysiology and management. Arch Intern Med 1992; 152(10): 1977–84
- Asmar R, Safavian A, Tual JL, et al. Arterial and cardiac changes in hypertension in the elderly. Blood Press 1995; Suppl 3: 31–7
- Olutade B, Hall WD. Systolic hypertension in the elderly. Curr Probl Cardiol 1997; 22(8): 405–43
- Flack JM, Woolley A, Esunge P, et al. A rational approach to hypertension treatment in the older patient. Geriatrics 1992; 47(11): 24–8, 33–8
- O'Donnell CJ, Ridker PM, Glynn RJ, et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 1997; 95(5): 1132–7
- Whelton PK. Epidemiology of hypertension. Lancet 1994; 344(8915): 101–6
- Petrovitch H, Vogt TM, Berge KG, for the SHEP Cooperative Research Group. Isolated systolic hypertension: lowering the risk of stroke in older patients. Geriatrics 1992; 47(3): 30–2, 35–8
- SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265(24): 3255–64
- Potter JF. The SYST-EUR Study—calcium channel blockers coming of age? European Trial on Isolated Systolic Hypertension in the Elderly. J Hum Hypertens 1997; 11 (10): 619–20
- Staessen JA, Fagard R, Thijs L, et al, for the Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350(9080): 757–64
- Hamet P, Gong L. Antihypertensive therapy debate: contribution from the Shanghai Trial Of Nifedipine in the Elderly (STONE). J Hypertens Suppl 1996; 14(4): S9–S14
- Elnicki M, Kotchen TA. Hypertension: patient evaluation, indications for treatment. Geriatrics 1993; 48(4): 47–50, 59–62
- Fierro-Carrion GA, Ram CV. Nonsteroidal anti-inflammatory drugs (NSAIDs) and blood pressure. (Editorial) Am J Cardiol 1997; 80(6): 775–6
- Schillaci G, Verdecchia P, Borgioni C, et al. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 1994; 74(7): 714–9
- Burris JF. Practical considerations in treating the elderly hypertensive patient. Am J Med 1991; 90(4B): 28S–31S
- Vertes V. Weight reduction for control of systemic hypertension. Am J Cardiol 1987; 60(12): 48G–54G
- Dustan HP. Renal arterial disease and hypertension. Med Clin North Am 1997; 81 (5): 1199–212
- Spence JD. Pseudo-hypertension in the elderly: still hazy, after all these years. J Hum Hypertens 1997; 11 (10): 621–3